Paracetamol (acetaminophen) hypersensitivity.

Ann Allergy Asthma Immunol

Division of Allergy, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.

Published: October 1997

Background: Paracetamol (acetaminophen) intolerance can occur in less than 5% of aspirin-sensitive subjects as a result of inhibition of prostaglandin synthesis but hypersensitivity to paracetamol without aspirin sensitivity is rare.

Methods: We report a case of an acute life-threatening hypersensitivity reaction to paracetamol.

Results: An oral challenge with 125 mg of paracetamol was carried out and followed by generalized anaphylactic reaction. An oral provocation test with 500 mg aspirin was well tolerated in the patient.

Conclusion: An acute hypersensitivity reaction to paracetamol is described in this study. The results of the study suggest a real allergic mechanism rather than inhibition of prostaglandin synthesis as responsible.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1081-1206(10)63021-9DOI Listing

Publication Analysis

Top Keywords

paracetamol acetaminophen
8
inhibition prostaglandin
8
prostaglandin synthesis
8
hypersensitivity reaction
8
paracetamol
5
hypersensitivity
4
acetaminophen hypersensitivity
4
hypersensitivity background
4
background paracetamol
4
acetaminophen intolerance
4

Similar Publications

Background: Pain is a major challenge for patients with rheumatoid arthritis (RA), with many people suffering chronic pain. Current RA management guidelines focus on assessing and reducing disease activity using disease-modifying anti-rheumatic drugs (DMARDs). Consequently, pain care is often suboptimal, with growing evidence that analgesics are widely prescribed to patients with RA, despite potential toxicities and limited evidence for efficacy.

View Article and Find Full Text PDF

The use of asfotase alfa, a bone-targeted recombinant alkaline phosphatase (ALP) enzyme, for the treatment of adult-onset hypophosphatasia (HPP) remains controversial, particularly in patients without evident bone abnormalities. We report the case of a 41-year-old woman with a history of Graves' disease, who presented with progressive joint pain and severe fatigue. Despite the absence of bone lesions, the patient was diagnosed with HPP based on persistently low alkaline phosphatase levels, family history, and a novel heterozygous ALPL variant (p.

View Article and Find Full Text PDF

The impact of glidant addition on the loss-in-weight feeding of active pharmaceutical ingredients.

Int J Pharm

January 2025

Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium. Electronic address:

In recent years, continuous manufacturing (CM) has become increasingly popular in the pharmaceutical industry for the production of oral solid dosage (OSD) forms. Most of the newly developed active pharmaceutical ingredients (APIs) nowadays are extremely cohesive and sticky with a mean particle size particle of <100μm, a wide particle size distribution (PSD) and a high tendency to agglomerate, making them difficult to accurately dose using loss-in-weight equipment during CM. In this research paper, the effect of various glidants on the volumetric and gravimetric feeding of several APIs was assessed.

View Article and Find Full Text PDF

A mitochondria-targeted nanozyme with enhanced antioxidant activity to prevent acute liver injury by remodeling mitochondria respiratory chain.

Biomaterials

January 2025

Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 100190, PR China. Electronic address:

Developing nanomedicines with enhanced activity to scavenge reactive oxygen species (ROS) has emerged as a promising strategy for addressing ROS-associated diseases, such as drug-induced liver injury. However, designing nanozymes that not only remove ROS but also accelerate the repair of damaged liver cells remains challenging. Here, a two-pronged black phosphorus/Ceria nanozyme with mitochondria-targeting ability (TBP@CeO) is designed.

View Article and Find Full Text PDF

Introduction: Patients poisoned with paracetamol are treated with acetylcysteine. In patients without hepatocellular injury, an increased prothrombin time or international normalized ratio has been observed during acetylcysteine administration. The international normalized ratio is preferred as it is a standardized calculation of prothrombin time independent of reagents and machinery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!